Finance

Lists
TTRX:NASDAQ
Turn Therapeutics Inc
11,64 US$
0,00%
(0,00) 1D
6 ოქტ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TTRX...
Mkt. cap
382,92 მლნ.
Avg. vol.
144,14 ათ.
Volume
154,00
52-wk high
26,50 US$
52-wk low
2,57 US$
EPS
-0,29 US$
Shares outstanding
29,79 მლნ.
No. of employees
2
Mkt. cap
382,92 მლნ.
Avg. vol.
144,14 ათ.
Volume
154,00
52-wk high
26,50 US$
52-wk low
2,57 US$
EPS
-0,29 US$
Shares outstanding
29,79 მლნ.
No. of employees
2
News stories
From web sources and news partners
TipRanks
TipRanks
·
2 საათის წინ
Turn Therapeutics Updates GX-03 Program and Pipeline Outlook
About Turn Therapeutics Inc
CEO-
Employees2
Founded2015
HeadquartersWestlake Village, კალიფორნია, ამერიკის შეერთებული შტატები
SectorPharmaceutical industry
Websiteturntherapeutics.com
Analyst ratings
Based on 4 analysts giving stock ratings to TTRX in the past 3 months
Hold
Buy
2
Hold
0
Sell
2
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for TTRX in the last 3 months.
Highest
Current 11,64 US$
24,00 US$ (+106,19%)
Average
15,00 US$ (+28,87%)
Lowest
10,00 US$ (-14,09%)
Analyst
Recommendation
Action
Price target
Projected
Date
Dev Prasad
Lucid Capital
Buy
Initiated
24,00 US$
+106,2%
09/24/2026
Karen Sterling
Westpark Capital
Sell
Downgraded
10,00 US$
-14,1%
09/14/2026
Unknown Analyst
WBB Securities
Sell
Downgraded
10,00 US$
-14,1%
09/14/2026
Rick Bienkowski
Ladenburg Thalmann & Co.
Buy
Maintained
16,00 US$
+37,5%
08/13/2026
Jason Kolbert
D. Boral Capital
Buy
Initiated
8,00 US$
-31,3%
12/29/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
-
-
-
-
Cost of goods sold
-
496,95 ათ.
477,65 ათ.
638,75 ათ.
Cost of revenue
-
496,95 ათ.
477,65 ათ.
638,75 ათ.
Research and development expenses
158,70 ათ.
34,93 ათ.
109,43 ათ.
475,06 ათ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,75 მლნ.
2,16 მლნ.
1,14 მლნ.
1,15 მლნ.
Operating expense
1,91 მლნ.
2,19 მლნ.
1,25 მლნ.
1,63 მლნ.
Total operating expenses
1,91 მლნ.
2,69 მლნ.
1,72 მლნ.
2,27 მლნ.
Operating income
-1,91 მლნ.
-2,69 მლნ.
-1,72 მლნ.
-2,27 მლნ.
Other non operating income
4,26 ათ.
2,96 მლნ.
703,14 ათ.
-3,34 მლნ.
EBT including unusual items
-1,90 მლნ.
279,07 ათ.
-970,97 ათ.
-5,85 მლნ.
EBT excluding unusual items
-1,90 მლნ.
279,07 ათ.
-970,97 ათ.
-5,85 მლნ.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1,90 მლნ.
279,07 ათ.
-970,97 ათ.
-5,85 მლნ.
Net profit margin
-
-
-
-
Earnings per share
-
-
-0,04
-
Interest and investment income
5,11 ათ.
14,18 ათ.
49,68 ათ.
-
Interest expense
-
-
-
-241,36 ათ.
Net interest expenses
5,11 ათ.
14,18 ათ.
49,68 ათ.
-241,36 ათ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-1,90 მლნ.
-2,68 მლნ.
-1,71 მლნ.
-2,25 მლნ.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები